Process View
Any process that modulates the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of MHC class II.

In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "regulation of mhc class ii biosynthetic process"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| CXCL1 | chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) | 0.988 | Human | |
| CXCL10 | chemokine (C-X-C motif) ligand 10 | 0.937 | Human | |
| CXCL11 | chemokine (C-X-C motif) ligand 11 | 0.887 | Human | |
| CXCL5 | chemokine (C-X-C motif) ligand 5 | 0.715 | Human | |
| CXCL2 | chemokine (C-X-C motif) ligand 2 | 0.674 | ||
| TIRAP | toll-interleukin 1 receptor (TIR) domain containing adaptor protein | 0.668 | ||
| IL8 | interleukin 8 | 0.653 | ||
| IL4R | interleukin 4 receptor | 0.406 | ||
| PF4 | platelet factor 4 | 0.377 | ||
| DPP4 | dipeptidyl-peptidase 4 | 0.321 | ||
| IL2RG | interleukin 2 receptor, gamma | 0.212 | ||
| TICAM2 | toll-like receptor adaptor molecule 2 | 0.184 | ||
| LY96 | lymphocyte antigen 96 | 0.156 | ||
| CXCL6 | chemokine (C-X-C motif) ligand 6 (granulocyte chemotactic protein 2) | 0.156 | Human | |
| HBA2 | hemoglobin, alpha 2 | 0.150 | ||
| CCL8 | chemokine (C-C motif) ligand 8 | 0.146 | ||
| MPO | myeloperoxidase | 0.100 | ||
| ITGA2B | integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41) | 0.085 | ||
| PPBP | pro-platelet basic protein (chemokine (C-X-C motif) ligand 7) | 0.082 | Human | |
| PF4V1 | platelet factor 4 variant 1 | 0.076 | Human | |
| S100A12 | S100 calcium binding protein A12 | 0.074 | ||
| CCL20 | chemokine (C-C motif) ligand 20 | 0.056 | ||
| CXCR3 | chemokine (C-X-C motif) receptor 3 | 0.052 | ||
| IDO1 | indoleamine 2,3-dioxygenase 1 | 0.051 | ||
| TFEC | transcription factor EC | 0.045 | ||
| BPI | bactericidal/permeability-increasing protein | 0.042 | ||
| GFI1 | growth factor independent 1 transcription repressor | 0.042 | ||
| NFE2 | nuclear factor (erythroid-derived 2), 45kDa | 0.036 | ||
| MS4A3 | membrane-spanning 4-domains, subfamily A, member 3 (hematopoietic cell-specific) | 0.035 | ||
| CCL7 | chemokine (C-C motif) ligand 7 | 0.034 | ||
| HBD | hemoglobin, delta | 0.032 | ||
| PSMA5 | proteasome (prosome, macropain) subunit, alpha type, 5 | 0.031 | ||
| MMP12 | matrix metallopeptidase 12 (macrophage elastase) | 0.030 | ||
| LCN2 | lipocalin 2 | 0.028 | ||
| CXCL13 | chemokine (C-X-C motif) ligand 13 | 0.028 | ||
| APOBR | apolipoprotein B receptor | 0.028 | ||
| PLEK | pleckstrin | 0.026 | ||
| IFNG | interferon, gamma | 0.026 | ||
| MOBKL2B | MOB1, Mps One Binder kinase activator-like 2B (yeast) | 0.025 | ||
| APOL1 | apolipoprotein L, 1 | 0.025 | ||
| STAT6 | signal transducer and activator of transcription 6, interleukin-4 induced | 0.025 | ||
| SKI | v-ski sarcoma viral oncogene homolog (avian) | 0.024 | ||
| CXCL3 | chemokine (C-X-C motif) ligand 3 | 0.023 | Human | |
| LAMP3 | lysosomal-associated membrane protein 3 | 0.023 | ||
| CEBPA | CCAAT/enhancer binding protein (C/EBP), alpha | 0.023 | ||
| HBB | hemoglobin, beta | 0.022 | ||
| SELE | selectin E | 0.022 | ||
| IL15RA | interleukin 15 receptor, alpha | 0.022 | ||
| UBD | ubiquitin D | 0.022 | ||
| CTSG | cathepsin G | 0.022 | ||
| IL6 | interleukin 6 (interferon, beta 2) | 0.021 | ||
| CCL18 | chemokine (C-C motif) ligand 18 (pulmonary and activation-regulated) | 0.020 | ||
| EFNA1 | ephrin-A1 | 0.020 | ||
| APOL3 | apolipoprotein L, 3 | 0.020 | ||
| RSAD2 | radical S-adenosyl methionine domain containing 2 | 0.019 | ||
| CCL2 | chemokine (C-C motif) ligand 2 | 0.019 | ||
| IFIT2 | interferon-induced protein with tetratricopeptide repeats 2 | 0.019 | ||
| CLEC4G | C-type lectin domain family 4, member G | 0.018 | ||
| IL10 | interleukin 10 | 0.018 | ||
| ITGB3 | integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61) | 0.018 | ||
| GBP4 | guanylate binding protein 4 | 0.018 | ||
| GPR97 | G protein-coupled receptor 97 | 0.018 | ||
| CH25H | cholesterol 25-hydroxylase | 0.017 | ||
| VCAM1 | vascular cell adhesion molecule 1 | 0.017 | ||
| IFI27 | interferon, alpha-inducible protein 27 | 0.017 | ||
| ALAS2 | aminolevulinate, delta-, synthase 2 | 0.016 | ||
| CLC | Charcot-Leyden crystal protein | 0.016 | ||
| RARA | retinoic acid receptor, alpha | 0.016 | ||
| HOXA10 | homeobox A10 | 0.016 | ||
| CXCL9 | chemokine (C-X-C motif) ligand 9 | 0.016 | Human | |
| KLF1 | Kruppel-like factor 1 (erythroid) | 0.016 | ||
| PRG2 | proteoglycan 2, bone marrow (natural killer cell activator, eosinophil granule major basic protein) | 0.016 | ||
| MMP9 | matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) | 0.016 | ||
| RNASE3 | ribonuclease, RNase A family, 3 | 0.015 | ||
| RPS27 | ribosomal protein S27 | 0.015 | ||
| DEFA4 | defensin, alpha 4, corticostatin | 0.015 | ||
| GP5 | glycoprotein V (platelet) | 0.015 | ||
| BIRC3 | baculoviral IAP repeat containing 3 | 0.015 | ||
| CAMP | cathelicidin antimicrobial peptide | 0.015 | ||
| IFI44L | interferon-induced protein 44-like | 0.014 | ||
| GATA1 | GATA binding protein 1 (globin transcription factor 1) | 0.014 | ||
| POU2F2 | POU class 2 homeobox 2 | 0.014 | ||
| AZU1 | azurocidin 1 | 0.014 | ||
| IL11 | interleukin 11 | 0.014 | ||
| HP | haptoglobin | 0.014 | ||
| CMTM6 | CKLF-like MARVEL transmembrane domain containing 6 | 0.014 | ||
| EP300 | E1A binding protein p300 | 0.013 | ||
| MMP7 | matrix metallopeptidase 7 (matrilysin, uterine) | 0.013 | ||
| ALB | albumin | 0.013 | ||
| HIPK2 | homeodomain interacting protein kinase 2 | 0.013 | ||
| NRGN | neurogranin (protein kinase C substrate, RC3) | 0.013 | ||
| IL15 | interleukin 15 | 0.013 | ||
| VPREB1 | pre-B lymphocyte 1 | 0.012 | ||
| MMP8 | matrix metallopeptidase 8 (neutrophil collagenase) | 0.012 | ||
| SERPINA1 | serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1 | 0.012 | ||
| RARRES1 | retinoic acid receptor responder (tazarotene induced) 1 | 0.012 | ||
| MESDC2 | mesoderm development candidate 2 | 0.012 | ||
| OASL | 2'-5'-oligoadenylate synthetase-like | 0.011 | ||
| CEACAM8 | carcinoembryonic antigen-related cell adhesion molecule 8 | 0.011 | ||
| S100A8 | S100 calcium binding protein A8 | 0.011 | ||
| TLR1 | toll-like receptor 1 | 0.011 | ||
| CCL13 | chemokine (C-C motif) ligand 13 | 0.011 | ||
| LTF | lactotransferrin | 0.011 | ||
| MMP10 | matrix metallopeptidase 10 (stromelysin 2) | 0.011 | ||
| CCL19 | chemokine (C-C motif) ligand 19 | 0.011 | ||
| CCL4 | chemokine (C-C motif) ligand 4 | 0.011 | ||
| HBG2 | hemoglobin, gamma G | 0.011 | ||
| FOLR3 | folate receptor 3 (gamma) | 0.011 | ||
| LIPG | lipase, endothelial | 0.010 | ||
| OAS2 | 2'-5'-oligoadenylate synthetase 2, 69/71kDa | 0.010 | ||
| HERPUD1 | homocysteine-inducible, endoplasmic reticulum stress-inducible, ubiquitin-like domain member 1 | 0.010 |